Feedback / Questions
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
https://www.globenewswire.com/news-release/2026/02/22/3242267/0/en/MoonLake-Announces-Positive-Topline-Results-from-its-Phase-2-Clinical-Trial-of-Sonelokimab-in-Axial-Spondyloarthritis-and-Reports-2025-Financial-Results.html
Feb 22, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next